Liquidia LQDA
NASDAQ LQDA
$68.47 +0.79 (+1.17%)
As of: Sep 9, 2026 · 1:49 PM EDT

Liquidia (LQDA) Other Operating Expenses (2020 - 2026)

Liquidia (LQDA) posted Other Operating Expenses of $11.5 million for Q2 2026, down 2.55% on a QoQ basis from $11.9 million in Q1 2026, and up 671.54% year-over-year from $1.5 million in Q2 2025.

Analysis

Liquidia (LQDA) Other Operating Expenses (2020 - 2026) Analysis & Trends

Liquidia has reported Other Operating Expenses for 7 years, with the latest figure at $11.5 million in Q2 2026.

  • On a quarterly basis, Other Operating Expenses rose 671.54% year-over-year to $11.5 million in Q2 2026; TTM through Jun 2026 was $33.6 million, a 466.83% increase from a year earlier, with the FY2025 full-year figure at $13.2 million, up 125.24% from the prior year.
  • Other Operating Expenses was $11.5 million for Q2 2026 at Liquidia, down from $11.9 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $11.9 million in Q1 2026, with the low at $570000.0 in Q3 2023.
  • Average Other Operating Expenses over 5 years is $2.7 million, with a median of $1.4 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2026: Other Operating Expenses fell 22.97% in 2023, then soared 681.28% in 2026.
  • Over 5 years, Other Operating Expenses stood at $694000.0 in 2022, then jumped by 43.08% to $993000.0 in 2023, then surged by 36.35% to $1.4 million in 2024, then surged by 421.05% to $7.1 million in 2025, then surged by 63.71% to $11.5 million in 2026.
  • The last three Other Operating Expenses figures came in at $11.5 million (Q2 2026), $11.9 million (Q1 2026), and $7.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.47 Bn 624.71 Bn 17.26 Bn
2 AbbVie 439.99 Bn 433.42 Bn 12.70 Bn
3 Merck 365.45 Bn 358.31 Bn 12.21 Bn
4 Novartis Ag 266.57 Bn 258.88 Bn 11.24 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn
7 Revolution Medicines 44.23 Bn 44.23 Bn -
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn
10 Liquidia 6.09 Bn 5.81 Bn 160.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.55 Mn
Mar 31, 2026 11.85 Mn
Dec 31, 2025 7.06 Mn
Sep 30, 2025 3.17 Mn
Jun 30, 2025 1.50 Mn
Mar 31, 2025 1.52 Mn
Dec 31, 2024 1.35 Mn
Sep 30, 2024 1.57 Mn
Jun 30, 2024 1.49 Mn
Mar 31, 2024 1.47 Mn
Dec 31, 2023 993,000.00
Sep 30, 2023 570,000.00
Jun 30, 2023 671,000.00
Mar 31, 2023 654,000.00
Dec 31, 2022 694,000.00
Sep 30, 2022 740,000.00
Jun 30, 2022 731,000.00
Mar 31, 2022 694,000.00
Dec 31, 2021 726,000.00
Sep 30, 2021 890,000.00